Systemic lupus erythematosus diagnosis and management

Area of Science:

• Rheumatology
• Immunology
• Internal Medicine

Background:

• Systemic lupus erythematosus (SLE) presents diagnostic and management challenges due to insidious onset, diverse symptoms, and variable disease patterns.
• Early diagnostic tests for SLE lack specificity, and later-stage tests may only detect organ damage.
• Disease flares are unpredictable and not consistently linked to biomarkers, complicating patient monitoring.

Purpose of the Study:

• To review the current state of diagnosis and management for systemic lupus erythematosus (SLE).
• To highlight new approaches and anticipated advances in SLE patient care.
• To address the complexities of SLE in pediatric and geriatric populations.

Main Methods:

• Literature review focusing on recent advances in SLE diagnosis and management.
• Analysis of current therapeutic interventions and their limitations.
• Exploration of the biological basis of SLE and its translation to clinical practice.

Main Results:

• Despite therapeutic improvements, current drugs inadequately control SLE in many patients, with off-target effects emerging over time.
• Improved survival rates reveal long-term treatment effects, underscoring the need for better disease control.
• Advances in understanding SLE pathogenesis are leading to more effective patient care strategies.

Conclusions:

• SLE diagnosis remains challenging due to non-specific early tests and variable presentation.
• Effective management of SLE requires addressing disease variability, unpredictable flares, and treatment-related toxicities.
• Ongoing research into the biological underpinnings of SLE promises improved diagnostic and therapeutic strategies for patients.